About this episode
Join Doctor Sofia Ramiro and Professors Janet Pope and Atul Deodhar, as they review and discuss key data from ACR 2025 across RA, PsA, and axSpA, focusing on implications for clinical practice.
Get every episode summarized
Each time The IMID Forum publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The IMID Forum
Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
The IMID Forum
Apr 14, 202616:32failed
Author Interview: Professor Helena Marzo-Ortega, March 2026
The IMID Forum
Apr 9, 202637:39failed
Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi pre...
The IMID Forum
Mar 26, 202610:02failed
Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeuti...
The IMID Forum
Mar 19, 202633:29failed